RECRUITING

St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to evaluate the effectiveness of offering self-sampled human papillomavirus (HPV) tests in increasing participation in cervical cancer screening, compared to the standard of care clinician-sampled test. The primary study endpoints are (1) patients' acceptability of self-sampled HPV tests vs. clinician-sampled test, and (2) patients' completion of self-sampled HPV test. The secondary study endpoint to be measured is the increase in cervical cancer screenings of any type in the PSH St. Joseph's residency clinic patient population.

Official Title

Increasing Cancer Screening Among Female Patients At PSH St. Joseph's Residency Clinic: Offering a Self-sampling Option in Clinic

Quick Facts

Study Start:2023-09-18
Study Completion:2025-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05092022

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:30 Years to 65 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Eligible but out-of-date for cervical cancer screening
  2. * Able to speak, read, and communicate well in English or Spanish
  3. * Not at greater than average risk for cervical cancer
  1. * Pregnant
  2. * Incarcerated
  3. * Greater than average risk for cervical cancer, for example:
  4. * Already diagnosed with high-grade precancerous cervical cancer or cervical lesions
  5. * Has a compromised immune system
  6. * Unable to speak, read, and communicate well in English or Spanish
  7. * Unable or unwilling to give implied consent or otherwise complete study requirements

Contacts and Locations

Study Contact

Christina Scartozzi, DO
CONTACT
610-208-4610
cscartozzi@pennstatehealth.psu.edu
Leonard Kishel
CONTACT
717-531-0003
lkishel@pennstatehealth.psu.edu

Principal Investigator

Christina Scartozzi, DO
PRINCIPAL_INVESTIGATOR
Penn State College of Medicine

Study Locations (Sites)

Penn State Health St. Joseph's
Reading, Pennsylvania, 19605
United States

Collaborators and Investigators

Sponsor: Milton S. Hershey Medical Center

  • Christina Scartozzi, DO, PRINCIPAL_INVESTIGATOR, Penn State College of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-18
Study Completion Date2025-06-30

Study Record Updates

Study Start Date2023-09-18
Study Completion Date2025-06-30

Terms related to this study

Keywords Provided by Researchers

  • self-sampling
  • cervical cancer

Additional Relevant MeSH Terms

  • Cervical Cancer Screening